BCAX Annual SG&A
$9.27 M
+$2.93 M+46.15%
01 December 2023
Summary:
As of January 23, 2025, BCAX annual selling, general & administrative expenses is $9.27 million, with the most recent change of +$2.93 million (+46.15%) on December 1, 2023. During the last 3 years, it has risen by +$2.93 million (+46.15%). BCAX annual SG&A is now at all-time high.BCAX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Quarterly SG&A
$4.76 M
0.00%
30 September 2024
Summary:
As of January 23, 2025, BCAX quarterly selling, general & administrative expenses is $4.76 millionOver the past year, it has increased by +$2.17 million (+83.87%). BCAX quarterly SG&A is now at all-time high.BCAX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX TTM SG&A
-$535.66 M
-$200.06 M-59.61%
30 September 2024
Summary:
As of January 23, 2025, BCAX TTM selling, general & administrative expenses is -$535.66 million, with the most recent change of -$200.06 million (-59.61%) on September 30, 2024. Over the past year, it has dropped by -$538.25 million (-20773.79%). BCAX TTM SG&A is now -250.06% below its all-time high of $4.76 million, reached on September 30, 2024.BCAX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +46.1% | +83.9% | -10000.0% |
| 3 y3 years | +46.1% | +83.9% | -10000.0% |
| 5 y5 years | +46.1% | +83.9% | -10000.0% |
BCAX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +46.1% | at high | +83.9% | -250.1% | at low |
| 5 y | 5-year | at high | +46.1% | at high | +83.9% | -250.1% | at low |
| alltime | all time | at high | +46.1% | at high | +83.9% | -250.1% | at low |
Bicara Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.76 M(+83.9%) | $4.76 M(+83.9%) |
| Dec 2023 | $9.27 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $2.59 M | $2.59 M |
| Dec 2022 | $6.34 M | - | - |
FAQ
- What is Bicara Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Bicara Therapeutics?
- What is Bicara Therapeutics annual SG&A year-on-year change?
- What is Bicara Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Bicara Therapeutics?
- What is Bicara Therapeutics quarterly SG&A year-on-year change?
- What is Bicara Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Bicara Therapeutics?
- What is Bicara Therapeutics TTM SG&A year-on-year change?
What is Bicara Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of BCAX is $9.27 M
What is the all time high annual SG&A for Bicara Therapeutics?
Bicara Therapeutics all-time high annual selling, general & administrative expenses is $9.27 M
What is Bicara Therapeutics annual SG&A year-on-year change?
Over the past year, BCAX annual selling, general & administrative expenses has changed by +$2.93 M (+46.15%)
What is Bicara Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of BCAX is $4.76 M
What is the all time high quarterly SG&A for Bicara Therapeutics?
Bicara Therapeutics all-time high quarterly selling, general & administrative expenses is $4.76 M
What is Bicara Therapeutics quarterly SG&A year-on-year change?
Over the past year, BCAX quarterly selling, general & administrative expenses has changed by +$2.17 M (+83.87%)
What is Bicara Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of BCAX is -$535.66 M
What is the all time high TTM SG&A for Bicara Therapeutics?
Bicara Therapeutics all-time high TTM selling, general & administrative expenses is $4.76 M
What is Bicara Therapeutics TTM SG&A year-on-year change?
Over the past year, BCAX TTM selling, general & administrative expenses has changed by -$538.25 M (-20773.79%)